Notice on matters involving the company in litigation
2024 Semi-Annual Equity Distribution Implementation Notice
Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications
Announcement on the resignation of the company\'s deputy general manager
Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications
Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications
Announcement on holding the 2024 semi-annual results briefing
Announcement regarding the profit distribution plan for the first half of 2024.
Full text of the 2024 semi-annual report.
Announcement of the resolution of the 10th meeting of the 9th Supervisory Board.
Risk Continual Assessment Report of General Technology Group Finance Co., Ltd.
Half-year evaluation report of the "Quality Improvement and Efficiency Increase for Return" action plan for the year 2024.
Announcement of the resolution of the 19th meeting of the 9th board of directors.
Summary of Half-Year Report in 2024.
Announcement regarding the subsidiary's approval of the marketing authorization application for chemical raw material active pharmaceutical ingredient.
Announcement regarding subsidiary obtaining pharmaceutical supplementary application approval letter.
Announcement on the Progress of Planning Changes in Actual Controllership of Important Equity-Participating Companies
Legal Opinion on the 2024 Third Interim Shareholders Meeting of China Meheco Group Co., Ltd.
Announcement of the resolution of the third interim shareholders meeting in 2024.
Announcement of the Resolution of the 18th Meeting of the Ninth Board of Directors.
No Data
No Data